Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697784 · ClinicalTrials.gov registry record · NA
Post-Approval Study of the TREO Abdominal Stent-Graft System
A NA study of Abdominal Aortic Aneurysm, sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 338
- Enrollment target
- 20
- Study locations
NCT04697784 is a NA study of Abdominal Aortic Aneurysm that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 338 participants, below the 433-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (22% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT04697784, a NA study of Abdominal Aortic Aneurysm, is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
Conditions Studied
Interventions
- DEVICE TREO Abdominal Stent-Graft System
Study Locations (20)
Florida
- Malcom Randall VA Medical Center - Gainesville
- University of Florida - Gainesville
- Coastal Vascular and Interventional - Pensacola
- University of South Florida / Tampa General Hospital - Tampa
California
- University of California, San Francisco-Fresno - Fresno
- University of California, San Diego - La Jolla
- VA San Diego - San Diego
Arizona
- Vascular Surgery Specialists - Phoenix
- Pima Heart and Vascular - Tucson
Georgia
- Piedmont Heart Institute - Atlanta
- Northside Hospital - Atlanta
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
Michigan
- McLaren Bay Region - Bay City
- Henry Ford Hospital - Detroit
Colorado
- University of Colorado Anschutz - Aurora
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04697784
The ClinicalTrials.gov registry entry for NCT04697784 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 433-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (22% lower). The listed sponsor is Bolton Medical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which TREO Abdominal Stent-Graft System is the first listed.
NCT04697784 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT04697784 about?
NCT04697784 is a clinical study titled "Post-Approval Study of the TREO Abdominal Stent-Graft System". The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
What is the current status of trial NCT04697784?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 338 participants. The study started on 2021-01-20. Estimated completion is 2027-07-31.
What conditions does trial NCT04697784 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT04697784?
The interventions under investigation include: TREO Abdominal Stent-Graft System (DEVICE).
Who is sponsoring clinical trial NCT04697784?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04697784 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.